Maternal administration of bisphenol A alters the microglial profile in the neocortex of mouse weanlings

Nao Kagawa1, Tetsuji Nagao1

  • 1Department of Life Science, Kindai University, Osaka, Japan.

Congenital Anomalies
|March 31, 2020
PubMed

Insights

Bisphenol A (BPA) exposure disrupts normal brain development by increasing microglial activation and neuroinflammation in the developing neocortex. This study reveals BPA

Area of Science:

  • Neuroscience
  • Toxicology
  • Developmental Biology

Background:

  • Bisphenol A (BPA) is a known endocrine disruptor linked to abnormal neurogenesis in the developing neocortex.
  • The precise mechanisms of BPA's neurotoxicity, particularly concerning neuroinflammation, remain incompletely understood.

Purpose of the Study:

  • To investigate the impact of BPA exposure on microglial morphology and pro-inflammatory cytokine gene expression in the newborn mouse neocortex.
  • To elucidate the role of neuroinflammation in BPA-induced neurodevelopmental toxicity.

Main Methods:

  • ICR mice were exposed to BPA (200 μg/kg/d) from gestational day 6 through post-partum day 21.
  • Microglial morphology and the gene expression of pro-inflammatory factors were assessed in weanlings.

Main Results:

  • BPA-exposed weanlings exhibited an increased number of amoeboid-type microglia, indicating altered microglial activation states.
  • A disruption in the M1/M2 microglial ratio was observed, suggesting impaired microglial differentiation.
  • Abnormal gene expression patterns for pro-inflammatory factors were detected in the neocortex.

Conclusions:

  • Prenatal and early postnatal BPA exposure induces microglial activation and neuroinflammation in the developing neocortex.
  • These inflammatory changes are likely contributors to the known neurodevelopmental toxicity of BPA.
  • Targeting neuroinflammation may offer a strategy to mitigate BPA's adverse effects on brain development.